Literature DB >> 20132079

Trough infliximab concentration may predict long-term maintenance of infliximab in ankylosing spondylitis.

D Chu Miow Lin, D Mulleman, N Azzopardi, I Griffoul-Espitalier, J-P Valat, G Paintaud, P Goupille.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20132079     DOI： 10.3109/03009740903177745

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN： 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  4 in total

1.  Influence of methotrexate on infliximab pharmacokinetics and pharmacodynamics in ankylosing spondylitis.

Authors:  David Ternant; Denis Mulleman; Francine Lauféron; Céline Vignault; Emilie Ducourau; Daniel Wendling; Philippe Goupille; Gilles Paintaud
Journal:  Br J Clin Pharmacol       Date:  2012-01       Impact factor: 4.335

Review 2.  Therapeutic drug monitoring of infliximab in spondyloarthritis. A review of the literature.

Authors:  María José Fobelo Lozano; Reyes Serrano Giménez; Susana Sánchez Fidalgo
Journal:  Br J Clin Pharmacol       Date:  2019-08-06       Impact factor: 4.335

3.  Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases.

Authors:  Emilie Ducourau; Denis Mulleman; Gilles Paintaud; Delphine Chu Miow Lin; Francine Lauféron; David Ternant; Hervé Watier; Philippe Goupille
Journal:  Arthritis Res Ther       Date:  2011-06-27       Impact factor: 5.156

4.  Methotrexate effect on immunogenicity and long-term maintenance of adalimumab in axial spondyloarthritis: a multicentric randomised trial.

Authors:  Emilie Ducourau; Theo Rispens; Marine Samain; Emmanuelle Dernis; Fabienne Le Guilchard; Lucia Andras; Aleth Perdriger; Eric Lespessailles; Antoine Martin; Grégoire Cormier; Thomas Armingeat; Valérie Devauchelle-Pensec; Elisabeth Gervais; Benoit Le Goff; Annick de Vries; Eric Piver; Gilles Paintaud; Céline Desvignes; David Ternant; Hervé Watier; Philippe Goupille; Denis Mulleman
Journal:  RMD Open       Date:  2020-01-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.